Djibouti vs Lithuania: New cases tested for RR-/MDR-TB
Djibouti
100.0%
in 2022
Lithuania
100.0%
in 2024
Djibouti rank
1st
Lithuania rank
1st
New cases tested for RR-/MDR-TB over time
- Djibouti
- Lithuania
How they compare
Djibouti currently reports 100.0% against 100.0% in Lithuania, a difference of 0.0%.
Across all 9 years both countries report, Lithuania has been ahead every year.
Djibouti ranks 1st and Lithuania ranks 1st of 192 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 100.0% | 100.0% | Lithuania |
| 2010s | 65.7% | 100.0% | 34.3% | Lithuania |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Djibouti or Lithuania?
- Djibouti, at 100.0% against 100.0% in Lithuania as of 2022.
- What is the difference in new cases tested for rr-/mdr-tb between Djibouti and Lithuania?
- 0.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Lithuania?
- 9 years are reported by both, from 2005 to 2022.
- How do Djibouti and Lithuania rank globally for new cases tested for rr-/mdr-tb?
- Djibouti ranks 1st and Lithuania ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.